<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04311814</url>
  </required_header>
  <id_info>
    <org_study_id>2015-A01411-48</org_study_id>
    <nct_id>NCT04311814</nct_id>
  </id_info>
  <brief_title>The Valsalva Urethral Profile : a Measure to Assess Stress Urinary Incontinence</brief_title>
  <official_title>Valsalva Urethral Profile (VUP) : a New Measure to Assess Stress Urinary Incontinence in Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Poissy-Saint Germain Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Poissy-Saint Germain Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Clinical and paraclinical appraisal of stress urinary incontinence (SUI) is mainly based on
      the assessment of pelvic floor muscles (PFM) contraction and urethral mobility, the
      measurement of the maximum urethral closure pressure (MUCP) at rest by urethral pressure
      profilometry (UPP) and the measurement of the Valsalva leak point pressure (VLPP).

      Currently, MUCP and VLPP cannot be used for diagnosing SUI because they appear to be
      moderately correlated with the severity of SUI.

      The lack of a specific SUI biomarker could be the explanation for the poor predictive value
      of urodynamics and the ongoing debate on whether urodynamic testing before surgery has
      benefits. Our main objective was to study the value of a new urodynamic parameter in the
      diagnosis of female SUI: the Valsalva urethral profile (VUP)
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 15, 2016</start_date>
  <completion_date type="Actual">December 20, 2019</completion_date>
  <primary_completion_date type="Actual">September 25, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>We conducted a monocentric interventional study, carried out as part of routine care</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Correlation between v-MUCP and diagnosis of SUI</measure>
    <time_frame>through study completion, an average of 6 months</time_frame>
    <description>Spearman correlation between the v-MCUP value and the ICIQ score. The ICIQ score (International Consultation on Incontinence Questionnaire-Urinary Incontinence) is a validated score used to quantify urinary incontinence (ranging from 0 = no incontinence to 21 = severe incontinence). v-MUCP (Valsalva Maximal Urethral Closure Pressure) is a urodynamic measure (measured in cmH2O). The Spearman correlation coefficient assesses how well the relationship between two variables can be described using a monotonic function.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Correlation between v-MUCP and MUCP</measure>
    <time_frame>through study completion, an average of 6 months</time_frame>
    <description>Spearman correlation coefficient. The Spearman correlation coefficient assesses how well the relationship between two variables can be described using a monotonic function. v-MUCP (Valsalva Maximal Urethral Closure Pressure) and MUCP Maximal Urethral Closure Pressure are two urodynamics measures (cmH2O)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Correlation between v-MUCP and VLPP</measure>
    <time_frame>through study completion, an average of 6 months</time_frame>
    <description>Spearman correlation, v-MUCP (valsalva Maximal Urethral Closure Pressure, cmH2O) and VLPP (Valsalva Leak Point Pressure, cmH2O) are urodyamic measures</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Discrimination capacity of v-MUCP (valsalva Maximal Urethral Closure Pressure, cmH2O) for the diagnosis of SUI (ICIQ = 0 versus ICIQ &gt; 0)</measure>
    <time_frame>through study completion, an average of 6 months</time_frame>
    <description>ROC curve. A Receiver Operating Characteristic (ROC) Curve is a way to compare diagnostic tests. It is a plot of the true positive rate against the false positive rate</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">695</enrollment>
  <condition>Stress Urinary Incontinence</condition>
  <arm_group>
    <arm_group_label>v-MUCP value</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>All patients referred for urodynamics explorations will have a measure of the MUCP during a Valsalva manoeuver</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Maximum urethral closure pressure during Valsalva (v-MUCP)</intervention_name>
    <description>v-MUCP measurement was performed for all patients referred for urodynamic exploration of the lower urinary tract</description>
    <arm_group_label>v-MUCP value</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  women over the age of 18 years, referred for urodynamic exploration of the lower
             urinary tract, with or without lower urinary tract disorders (TUBA)

          -  women who gave their consent to participate in the study.

        Exclusion Criteria:

          -  pelvic organ prolapse (POP) ≥ stage 2 according to the POP-Q classification

          -  history of surgery for SUI and / or POP,

          -  acute urinary tract infection,

          -  proven neurological pathology,

          -  urine retention,

          -  a history of pneumothorax

          -  a lability of MUCP ≥ 15 cmH2O
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philippe Dompeyre, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Intercommunal Hsopital center of Poissy Saint Germain</affiliation>
  </overall_official>
  <reference>
    <citation>Petros PE, Ulmsten UI. An integral theory and its method for the diagnosis and management of female urinary incontinence. Scand J Urol Nephrol Suppl. 1993;153:1-93. Review.</citation>
    <PMID>8108659</PMID>
  </reference>
  <reference>
    <citation>DeLancey JO. Structural support of the urethra as it relates to stress urinary incontinence: the hammock hypothesis. Am J Obstet Gynecol. 1994 Jun;170(6):1713-20; discussion 1720-3.</citation>
    <PMID>8203431</PMID>
  </reference>
  <reference>
    <citation>DeLancey JO, Trowbridge ER, Miller JM, Morgan DM, Guire K, Fenner DE, Weadock WJ, Ashton-Miller JA. Stress urinary incontinence: relative importance of urethral support and urethral closure pressure. J Urol. 2008 Jun;179(6):2286-90; discussion 2290. doi: 10.1016/j.juro.2008.01.098. Epub 2008 Apr 18.</citation>
    <PMID>18423707</PMID>
  </reference>
  <reference>
    <citation>Bump RC, Elser DM, Theofrastous JP, McClish DK. Valsalva leak point pressures in women with genuine stress incontinence: reproducibility, effect of catheter caliber, and correlations with other measures of urethral resistance. Continence Program for Women Research Group. Am J Obstet Gynecol. 1995 Aug;173(2):551-7.</citation>
    <PMID>7645634</PMID>
  </reference>
  <reference>
    <citation>McGuire EJ, Fitzpatrick CC, Wan J, Bloom D, Sanvordenker J, Ritchey M, Gormley EA. Clinical assessment of urethral sphincter function. J Urol. 1993 Nov;150(5 Pt 1):1452-4.</citation>
    <PMID>8411422</PMID>
  </reference>
  <reference>
    <citation>Theofrastous JP, Bump RC, Elser DM, Wyman JF, McClish DK. Correlation of urodynamic measures of urethral resistance with clinical measures of incontinence severity in women with pure genuine stress incontinence. The Continence Program for Women Research Group. Am J Obstet Gynecol. 1995 Aug;173(2):407-12; discussion 412-4.</citation>
    <PMID>7645615</PMID>
  </reference>
  <reference>
    <citation>Bump RC, Mattiasson A, Bø K, Brubaker LP, DeLancey JO, Klarskov P, Shull BL, Smith AR. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol. 1996 Jul;175(1):10-7.</citation>
    <PMID>8694033</PMID>
  </reference>
  <reference>
    <citation>Kirschner-Hermanns R, Anding R, Rosier P, Birder L, Andersson KE, Djurhuus JC. Fundamentals and clinical perspective of urethral sphincter instability as a contributing factor in patients with lower urinary tract dysfunction--ICI-RS 2014. Neurourol Urodyn. 2016 Feb;35(2):318-23. doi: 10.1002/nau.22815. Review.</citation>
    <PMID>26872575</PMID>
  </reference>
  <reference>
    <citation>Avery K, Donovan J, Peters TJ, Shaw C, Gotoh M, Abrams P. ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Neurourol Urodyn. 2004;23(4):322-30.</citation>
    <PMID>15227649</PMID>
  </reference>
  <reference>
    <citation>Messelink B, Benson T, Berghmans B, Bø K, Corcos J, Fowler C, Laycock J, Lim PH, van Lunsen R, á Nijeholt GL, Pemberton J, Wang A, Watier A, Van Kerrebroeck P. Standardization of terminology of pelvic floor muscle function and dysfunction: report from the pelvic floor clinical assessment group of the International Continence Society. Neurourol Urodyn. 2005;24(4):374-80.</citation>
    <PMID>15977259</PMID>
  </reference>
  <reference>
    <citation>Fritel X, Fauconnier A, Bader G, Cosson M, Debodinance P, Deffieux X, Denys P, Dompeyre P, Faltin D, Fatton B, Haab F, Hermieux JF, Kerdraon J, Mares P, Mellier G, Michel-Laaengh N, Nadeau C, Robain G, de Tayrac R, Jacquetin B; French College of Gynaecologists and Obstetricians. Diagnosis and management of adult female stress urinary incontinence: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians. Eur J Obstet Gynecol Reprod Biol. 2010 Jul;151(1):14-9. doi: 10.1016/j.ejogrb.2010.02.041. Epub 2010 Mar 16. Review.</citation>
    <PMID>20236751</PMID>
  </reference>
  <reference>
    <citation>Nager CW, Schulz JA, Stanton SL, Monga A. Correlation of urethral closure pressure, leak-point pressure and incontinence severity measures. Int Urogynecol J Pelvic Floor Dysfunct. 2001;12(6):395-400.</citation>
    <PMID>11795644</PMID>
  </reference>
  <reference>
    <citation>Pizzoferrato AC, Fauconnier A, Fritel X, Bader G, Dompeyre P. Urethral Closure Pressure at Stress: A Predictive Measure for the Diagnosis and Severity of Urinary Incontinence in Women. Int Neurourol J. 2017 Jun;21(2):121-127. doi: 10.5213/inj.1732686.343. Epub 2017 Jun 21.</citation>
    <PMID>28673060</PMID>
  </reference>
  <reference>
    <citation>Dietz HP, Clarke B. The urethral pressure profile and ultrasound imaging of the lower urinary tract. Int Urogynecol J Pelvic Floor Dysfunct. 2001;12(1):38-41.</citation>
    <PMID>11294530</PMID>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>February 21, 2020</study_first_submitted>
  <study_first_submitted_qc>March 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 17, 2020</study_first_posted>
  <last_update_submitted>March 15, 2020</last_update_submitted>
  <last_update_submitted_qc>March 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Poissy-Saint Germain Hospital</investigator_affiliation>
    <investigator_full_name>Anne Cecile Pizzoferrato</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Stress Urinary Incontinence</keyword>
  <keyword>Urodynamics</keyword>
  <keyword>Maximal urethral cloture pressure</keyword>
  <keyword>Bladder neck mobility</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Enuresis</mesh_term>
    <mesh_term>Urinary Incontinence, Stress</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

